BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu WH, Wang HT, Sun Y, Xue ZC, Liang ML, Su WK. Antihyperuricemic and nephroprotective effects of extracts from Orthosiphon stamineus in hyperuricemic mice. J Pharm Pharmacol 2020;72:551-60. [PMID: 31910301 DOI: 10.1111/jphp.13222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hlophe NB, Opoku AR, Osunsanmi FO, Djarova-Daniels TG, Lawal OA, Mosa RA. A Lanosteryl Triterpene (RA-3) Exhibits Antihyperuricemic and Nephroprotective Effects in Rats. Molecules 2020;25:E4010. [PMID: 32887389 DOI: 10.3390/molecules25174010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xu L, Lin G, Yu Q, Li Q, Mai L, Cheng J, Xie J, Liu Y, Su Z, Li Y. Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice. Front Pharmacol 2021;12:645879. [PMID: 33959014 DOI: 10.3389/fphar.2021.645879] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Chen WD, Zhao YL, Sun WJ, He YJ, Liu YP, Jin Q, Yang XW, Luo XD. "Kidney Tea" and Its Bioactive Secondary Metabolites for Treatment of Gout. J Agric Food Chem 2020;68:9131-8. [PMID: 32786873 DOI: 10.1021/acs.jafc.0c03848] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]